+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dysmenorrhea Patch Market by End User (Clinic, Homecare, Hospital), Active Ingredient (Diclofenac, Ibuprofen, Lidocaine), Age Group, Distribution Channel, Patch Dose - Global Forecast 2025-2030- Product Image
Dysmenorrhea Patch Market by End User (Clinic, Homecare, Hospital), Active Ingredient (Diclofenac, Ibuprofen, Lidocaine), Age Group, Distribution Channel, Patch Dose - Global Forecast 2025-2030- Product Image
New

Dysmenorrhea Patch Market by End User (Clinic, Homecare, Hospital), Active Ingredient (Diclofenac, Ibuprofen, Lidocaine), Age Group, Distribution Channel, Patch Dose - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6150453
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pioneering the Next Generation of Dysmenorrhea Patch Solutions Through Innovative Drug Delivery, Enhanced Patient Comfort, and Personalized Therapeutic Strategies

An increasing number of women experience dysmenorrhea as a significant barrier to daily productivity and quality of life, prompting the emergence of non-invasive transdermal solutions. Dysmenorrhea patches offer a unique combination of sustained pain relief, improved gastrointestinal tolerability, and the flexibility to adhere to diverse lifestyles. This modality reduces peaks and troughs in drug concentration, translating to consistent symptom management and higher rates of patient adherence. A growing body of clinical observations highlights the value of patches in minimizing systemic side effects while delivering targeted therapeutic benefits.

This executive summary distills the critical developments shaping the dysmenorrhea patch landscape. It outlines transformative shifts in technology and regulatory policy, examines the cumulative impact of United States tariffs, and identifies granular segmentation insights. Additionally, it presents regional and corporate analyses, methodological rigor, and strategic recommendations for industry leaders. By synthesizing these dimensions, this report provides a holistic foundation for stakeholders seeking to navigate evolving dynamics and capitalize on emerging opportunities within the dysmenorrhea patch sector.

Groundbreaking Advances in Transdermal Technology and Patient Engagement Strategies Are Redefining the Dysmenorrhea Patch Market Landscape

Over the past several years, advances in transdermal matrix design, microneedle arrays, and permeation enhancers have propelled dysmenorrhea patches from proof-of-concept to mainstream therapeutic options. Integrating smart sensor technology into adhesive platforms now enables real-time feedback on adhesion integrity and skin health, fostering higher confidence among prescribers and end users. Simultaneously, digital therapeutics and mobile health applications have enhanced adherence tracking, patient education, and remote monitoring, bridging gaps between clinic visits.

At the same time, evolving patient engagement strategies emphasize personalized care pathways and value-based contracting, where outcomes determine reimbursement terms. This shift toward outcome-oriented agreements underscores the importance of demonstrating long-term efficacy, safety, and cost benefits. As stakeholders increasingly prioritize patient-centric approaches, the dysmenorrhea patch segment is poised for accelerated adoption, driven by a collaborative ecosystem that unites technology, healthcare delivery, and digital enablement.

Comprehensive Analysis of the 2025 United States Tariff Implications on Manufacturing Costs and Supply Chain Dynamics for Dysmenorrhea Patch Production

The introduction of revised tariff schedules in 2025 has generated notable shifts in the cost structures associated with dysmenorrhea patch production. Raw materials such as specialized polymers, drug compounds, and permeation enhancers imported into the United States now carry elevated duty rates. This change has compelled manufacturers to re-evaluate supplier portfolios, negotiate alternative sources, and explore near-shoring opportunities to mitigate cost pressure.

Consequently, downstream partners in distribution and clinical procurement have faced pricing adjustments that influence contract negotiations with payers and healthcare providers. To navigate these evolving dynamics, companies have intensified collaboration with logistics experts to optimize cross-border workflows, consolidated import volumes to achieve economies of scale, and advocated for regulatory waivers or preferential trade agreements. These combined measures have begun to stabilize supply chain resilience, ensuring that patient access to dysmenorrhea patches remains uninterrupted despite the tariff-driven headwinds.

Detailed Segmentation Insights Highlight Varied End Users, Active Ingredients, Age Groups, Distribution Channels, and Dosage Levels Driving Dysmenorrhea Patch Adoption

Analyzing the dysmenorrhea patch market through multiple lenses reveals distinct usage patterns and innovation demands. When examining end users across clinical settings, patches demonstrate strong uptake in outpatient clinics that value controlled administration, while homecare environments leverage their ease of use for self-management, and hospitals incorporate patches into multimodal pain relief protocols. Shifting focus to active ingredients, differential profiles of diclofenac, ibuprofen, and lidocaine cater to varying pain mechanisms and patient tolerability, driving targeted product development.

Age stratification further underscores the need for tailored approaches: younger patients aged 20 to 34 often prioritize discreet, once-daily dosing, whereas those between 35 and 49 emphasize sustained efficacy through life’s peak pressures, and adolescents require formulations that balance potency with gentle dermatological compatibility. Assessing distribution channels highlights how hospital pharmacies maintain clinician trust, retail pharmacies ensure broad accessibility, and online sales-comprising general e-commerce platforms and specialized pharmacy websites-offer discreet ordering combined with home delivery. Finally, dose variations spanning low, medium, and high strength empower prescribers to adjust treatment intensity based on pain severity, reinforcing the critical role of dosage flexibility in addressing diverse clinical profiles.

Regional Dynamics Reveal Unique Demand Drivers, Regulatory Environments, and Growth Trajectories Across Americas, EMEA, and Asia-Pacific Dysmenorrhea Patch Markets

Regional analysis of the dysmenorrhea patch landscape uncovers unique patterns of demand, regulatory alignment, and distribution maturity. In the Americas, strong reimbursement frameworks and well-established outpatient networks facilitate rapid integration of new formulations, supported by awareness campaigns that emphasize convenience and efficacy. Key markets benefit from partnerships between manufacturers and pharmacy chains, which streamline patient access and bolster adherence through loyalty programs.

Across Europe, the Middle East, and Africa, diverse regulatory pathways and jurisdictional reimbursement policies require adaptive market entry strategies. European markets often prioritize clinical evidence in centralized approval processes, while Middle Eastern stakeholders focus on private-sector collaborations to accelerate adoption. In Africa, innovative public-private alliances and donor support have expanded patch availability through community health initiatives. Meanwhile, the Asia-Pacific region presents a spectrum of growth drivers, from advanced healthcare infrastructure in developed economies to rising awareness and digital health expansion in emerging markets. Sophisticated e-commerce penetration further enables product reach, particularly in densely populated urban centers where convenience and discretion are paramount.

Strategic Profiles and Competitive Strategies of Leading Manufacturers Driving Innovation, Product Differentiation, and Market Penetration in Dysmenorrhea Patch Industry

Leading players in the dysmenorrhea patch arena are leveraging differentiated strategies to solidify their market positions. Key innovators focus on developing proprietary polymer matrices that optimize drug permeation and adhesion, while others pursue pipeline expansion through strategic licensing agreements for novel analgesic compounds. Collaborative research partnerships with academic institutions have accelerated the validation of next-generation transdermal platforms, yielding early data on enhanced drug release profiles and reduced application-site reactions.

On the commercial front, several manufacturers are deploying multi-channel marketing approaches that integrate physician education, patient support programs, and digital counseling services. Sophisticated supply chain frameworks, underpinned by regional manufacturing hubs, have improved responsiveness to demand fluctuations and tariff-driven cost pressures. Moreover, select companies are exploring acquisition opportunities to broaden their product portfolios, enabling cross-selling potential within women’s health and pain management segments. These strategic initiatives collectively underscore the competitive intensity and innovative momentum driving the dysmenorrhea patch industry.

Actionable Strategic Recommendations Empower Industry Leaders to Enhance Market Positioning, Improve Patient Access, and Drive Sustainable Growth in Dysmenorrhea Patch Segment

To capitalize on emerging opportunities, industry leaders should invest in next-generation transdermal research that integrates smart sensor technology for dynamic feedback on patch performance and patient adherence. Establishing cross-functional alliances among R&D, regulatory, and commercial teams will accelerate time to market while ensuring compliance with evolving global standards. In parallel, diversifying supply chains through dual-sourcing strategies and regional production facilities can offset tariff impacts and reduce lead times.

Enhancing patient engagement through digital health platforms-such as mobile apps for symptom tracking and personalized adherence reminders-will strengthen real-world data collection, informing targeted messaging and outcome-based partnerships. Additionally, customized education initiatives for healthcare providers can drive greater confidence in prescribing patches across varying patient demographics. Finally, proactive engagement with payers to demonstrate long-term cost-effectiveness and outcome improvements will secure favorable reimbursement terms, fostering sustainable growth and broader patient access.

Rigorous Methodological Framework Combining Primary Interviews, Secondary Data Analysis, and Quantitative Validation to Deliver Robust Dysmenorrhea Patch Market Insights

This research draws upon a multi-tiered methodological framework designed to ensure accuracy and depth. Primary data were gathered through structured interviews with pain management specialists, pharmacists, procurement officers, and patient advocacy groups, providing firsthand insights into clinical adoption drivers and patient preferences. Secondary sources-including peer-reviewed journals, regulatory filings, patent databases, and industry white papers-supplemented these qualitative findings with robust background information.

Quantitative analysis utilized sales data, import-export records, and distribution channel metrics to validate observed trends and corroborate stakeholder perspectives. Triangulation techniques were employed to cross-verify information, while data normalization protocols ensured consistency across disparate sources. Rigorous quality control processes, encompassing peer review by domain experts and iterative validation checkpoints, guarantee the reliability of conclusions and support actionable recommendations for decision-makers operating within the dysmenorrhea patch market.

Conclusive Insights Emphasize High-Impact Opportunities and Address Emerging Challenges in the Dysmenorrhea Patch Market Landscape

In synthesizing the multifaceted insights, it becomes clear that dysmenorrhea patches represent a transformative approach to menstrual pain management, blending technological innovation with patient convenience. The convergence of advanced transdermal platforms, digital adherence tools, and outcome-focused reimbursement models signals a critical inflection point for stakeholders. As regulatory landscapes continue to evolve and competitive dynamics intensify, companies that effectively align product innovation with evidence generation will capture significant share of voice.

Moving forward, sustained investment in formulation science, strategic partnerships, and real-world data initiatives will be essential. By proactively addressing supply chain vulnerabilities and engaging payers through value demonstration, organizations can secure long-term growth and broaden patient access. Ultimately, the dysmenorrhea patch landscape is poised for continued evolution, offering substantial opportunities for agile industry participants to lead in both clinical impact and market performance.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • End User
    • Clinic
    • Homecare
    • Hospital
  • Active Ingredient
    • Diclofenac
    • Ibuprofen
    • Lidocaine
  • Age Group
    • 20 To 34 Years
    • 35 To 49 Years
    • Adolescents
  • Distribution Channel
    • Hospital Pharmacy
    • Online Sales
      • General E-Commerce
      • Pharmacy Websites
    • Retail Pharmacy
  • Patch Dose
    • High Dose
    • Low Dose
    • Medium Dose
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Hisamitsu Pharmaceutical Co., Inc.
  • Noven Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Novartis AG
  • Teikoku Seiyaku Co., Ltd.
  • 3M Company
  • Viatris Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growth of biodegradable adhesive materials enhancing extended menstrual pain relief patches with minimal skin irritation
5.2. Rising integration of smart wearable sensors in dysmenorrhea patches for personalized pain monitoring and automated dosage adjustments
5.3. Expansion of over-the-counter distribution channels driving increased consumer accessibility to pain relief patches for menstrual cramps
5.4. Strategic partnerships between pharmaceutical companies and medical device manufacturers to accelerate clinical validation of transdermal dysmenorrhea therapies
5.5. Regulatory acceleration and evolving guidelines facilitating faster approval pathways for innovative transdermal analgesic patches targeting menstrual pain
5.6. Consumer preference shift toward natural and plant-based active ingredients in menstrual pain relief patches promoting cleaner label formulations
5.7. Technological advancements in micro-needle array patches enabling enhanced drug penetration and faster onset of dysmenorrhea relief
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dysmenorrhea Patch Market, by End User
8.1. Introduction
8.2. Clinic
8.3. Homecare
8.4. Hospital
9. Dysmenorrhea Patch Market, by Active Ingredient
9.1. Introduction
9.2. Diclofenac
9.3. Ibuprofen
9.4. Lidocaine
10. Dysmenorrhea Patch Market, by Age Group
10.1. Introduction
10.2. 20 To 34 Years
10.3. 35 To 49 Years
10.4. Adolescents
11. Dysmenorrhea Patch Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Sales
11.3.1. General E-Commerce
11.3.2. Pharmacy Websites
11.4. Retail Pharmacy
12. Dysmenorrhea Patch Market, by Patch Dose
12.1. Introduction
12.2. High Dose
12.3. Low Dose
12.4. Medium Dose
13. Americas Dysmenorrhea Patch Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Dysmenorrhea Patch Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Dysmenorrhea Patch Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Hisamitsu Pharmaceutical Co., Inc.
16.3.2. Noven Pharmaceuticals, Inc.
16.3.3. Pfizer Inc.
16.3.4. Novartis AG
16.3.5. Teikoku Seiyaku Co., Ltd.
16.3.6. 3M Company
16.3.7. Viatris Inc.
16.3.8. Dr. Reddy’s Laboratories Ltd.
16.3.9. Teva Pharmaceutical Industries Ltd.
16.3.10. Bayer AG
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. DYSMENORRHEA PATCH MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DYSMENORRHEA PATCH MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DYSMENORRHEA PATCH MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DYSMENORRHEA PATCH MARKET: RESEARCHAI
FIGURE 26. DYSMENORRHEA PATCH MARKET: RESEARCHSTATISTICS
FIGURE 27. DYSMENORRHEA PATCH MARKET: RESEARCHCONTACTS
FIGURE 28. DYSMENORRHEA PATCH MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DYSMENORRHEA PATCH MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY DICLOFENAC, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY DICLOFENAC, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY IBUPROFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY LIDOCAINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY 20 TO 34 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY 20 TO 34 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY 35 TO 49 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY 35 TO 49 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY ADOLESCENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY GENERAL E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY GENERAL E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY PHARMACY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY PHARMACY WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY HIGH DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY HIGH DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY LOW DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY LOW DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY MEDIUM DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DYSMENORRHEA PATCH MARKET SIZE, BY MEDIUM DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES DYSMENORRHEA PATCH MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 83. CANADA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. CANADA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. CANADA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 86. CANADA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 87. CANADA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 88. CANADA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 89. CANADA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. CANADA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. CANADA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 92. CANADA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 93. CANADA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 94. CANADA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 95. MEXICO DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. MEXICO DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. MEXICO DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 98. MEXICO DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 99. MEXICO DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 100. MEXICO DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 101. MEXICO DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. MEXICO DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. MEXICO DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 104. MEXICO DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 105. MEXICO DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 106. MEXICO DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 157. GERMANY DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. GERMANY DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. GERMANY DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 160. GERMANY DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 161. GERMANY DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 162. GERMANY DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 163. GERMANY DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. GERMANY DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. GERMANY DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 166. GERMANY DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 167. GERMANY DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 168. GERMANY DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 169. FRANCE DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. FRANCE DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. FRANCE DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 172. FRANCE DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 173. FRANCE DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 174. FRANCE DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 175. FRANCE DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. FRANCE DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. FRANCE DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 178. FRANCE DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 179. FRANCE DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 180. FRANCE DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 193. ITALY DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. ITALY DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. ITALY DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 196. ITALY DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 197. ITALY DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 198. ITALY DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 199. ITALY DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. ITALY DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. ITALY DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 202. ITALY DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 203. ITALY DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 204. ITALY DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 205. SPAIN DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. SPAIN DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SPAIN DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 208. SPAIN DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 209. SPAIN DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 210. SPAIN DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 211. SPAIN DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. SPAIN DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. SPAIN DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 214. SPAIN DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 215. SPAIN DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 216. SPAIN DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 253. DENMARK DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. DENMARK DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. DENMARK DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 256. DENMARK DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 257. DENMARK DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. DENMARK DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. DENMARK DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. DENMARK DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. DENMARK DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 262. DENMARK DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 263. DENMARK DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 264. DENMARK DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 277. QATAR DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. QATAR DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. QATAR DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 280. QATAR DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 281. QATAR DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 282. QATAR DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 283. QATAR DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. QATAR DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. QATAR DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 286. QATAR DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 287. QATAR DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 288. QATAR DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 289. FINLAND DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. FINLAND DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. FINLAND DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 292. FINLAND DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 293. FINLAND DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 294. FINLAND DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 295. FINLAND DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. FINLAND DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. FINLAND DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 298. FINLAND DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 299. FINLAND DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 300. FINLAND DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 325. EGYPT DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. EGYPT DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. EGYPT DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 328. EGYPT DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 329. EGYPT DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 330. EGYPT DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 331. EGYPT DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. EGYPT DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. EGYPT DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 334. EGYPT DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 335. EGYPT DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2018-2024 (USD MILLION)
TABLE 336. EGYPT DYSMENORRHEA PATCH MARKET SIZE, BY PATCH DOSE, 2025-2030 (USD MILLION)
TABLE 337. TURKEY DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. TURKEY DYSMENORRHEA PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. TURKEY DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 340. TURKEY DYSMENORRHEA PATCH MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 341. TURKEY DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 342. TURKEY DYSMENORRHEA PATCH MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 343. TURKEY DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. TURKEY DYSMENORRHEA PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. TURKEY DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 346. TURKEY DYSMENORRHEA PATCH MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 347. TURKEY DYSMENORRHEA PATCH MARK

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Dysmenorrhea Patch Market report include:
  • Hisamitsu Pharmaceutical Co., Inc.
  • Noven Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Novartis AG
  • Teikoku Seiyaku Co., Ltd.
  • 3M Company
  • Viatris Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG

Related Topics

Related Reports

Tianqi Dysmenorrhea Capsules Market by Distribution Channel (Hospital, Online Retail, Pharmacy), Formulation (Capsule, Granule, Patch), Age Group, Price Tier, Dosage Strength, Indication Type - Global Forecast 2025-2030 - Product Image

Tianqi Dysmenorrhea Capsules Market by Distribution Channel (Hospital, Online Retail, Pharmacy), Formulation (Capsule, Granule, Patch), Age Group, Price Tier, Dosage Strength, Indication Type - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Dysmenorrhea Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Dysmenorrhea Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 270 Pages
  • Global
From
Dysmenorrhea Treatment Market by Treatment Type (Non Pharmacological, Pharmacological), Drug Class (Hormonal Contraceptives, Nsaids), Route Of Administration, Distribution Channel, Application, End User - Global Forecast 2025-2030 - Product Image

Dysmenorrhea Treatment Market by Treatment Type (Non Pharmacological, Pharmacological), Drug Class (Hormonal Contraceptives, Nsaids), Route Of Administration, Distribution Channel, Application, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Dysmenorrhea Treatment - Global Strategic Business Report - Product Image

Dysmenorrhea Treatment - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Dysmenorrhea - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Dysmenorrhea - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.